phenotypeId,phenotypeName,clinicalDescription,metaDataJson
4046338000,Multifocal motor neuropathy,"Overview: Immune mediated, characterized by progressive asymmetric weakness and atrophy without sensory abnormalities. Presentation: Over at least a month, progressive asymmetric weakness usually beginning in the arms and hands. Wrist drop is often present. Assessment: EMG, NCS, neurologic exam with frequently preserved deep tendon reflexes. anti-GM 1 antibodies. History of use of anti-TNF alpha antibodies has been associated MMN. Plan: IVIG, does not respond to glucocorticoids or plasma exchange. Prognosis: Slowly progressive and eventually disabling in untreated patients.","{
	""oldPhenotypeId"" : [
		""4046338000""
	],
	""newPhenotypeId"" : [
		""4046338000""
	],
	""phenotypeId"" : [
		""4046338000""
	],
	""phenotypeName"" : [
		""Multifocal motor neuropathy""
	],
	""referentConceptId"" : [
		""4046338""
	],
	""clinicalDescription"" : [
		""Overview: Immune mediated, characterized by progressive asymmetric weakness and atrophy without sensory abnormalities. Presentation: Over at least a month, progressive asymmetric weakness usually beginning in the arms and hands. Wrist drop is often present. Assessment: EMG, NCS, neurologic exam with frequently preserved deep tendon reflexes. anti-GM 1 antibodies. History of use of anti-TNF alpha antibodies has been associated MMN. Plan: IVIG, does not respond to glucocorticoids or plasma exchange. Prognosis: Slowly progressive and eventually disabling in untreated patients.""
	],
	""literatureReview"" : [
		""""
	],
	""phenotypeNotes"" : [
		""""
	],
	""deprecate"" : [
		""""
	]
}"
